Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:29 UTC |
---|
HMDB ID | HMDB0000068 |
---|
Secondary Accession Numbers | - HMDB0000615
- HMDB00068
- HMDB00615
|
---|
Metabolite Identification |
---|
Common Name | Epinephrine |
---|
Description | Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system. |
---|
Structure | CNC[C@H](O)C1=CC(O)=C(O)C=C1 InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-(R)-Epinephrine | ChEBI | (-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol | ChEBI | (-)-Adrenaline | ChEBI | (R)-(-)-Adrenaline | ChEBI | (R)-(-)-Adnephrine | ChEBI | (R)-(-)-Epinephrine | ChEBI | (R)-(-)-Epirenamine | ChEBI | 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol | ChEBI | Adrenalin | ChEBI | Adrenaline | ChEBI | Epinefrina | ChEBI | Epinephrin | ChEBI | Epinephrinum | ChEBI | Epipen | ChEBI | Epipen JR | ChEBI | L-Adrenaline | ChEBI | Levoepinephrine | ChEBI | Primatene | ChEBI | Auvi-Q | Kegg | (-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol | Generator | (-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol | Generator | (-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol | HMDB | (-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol | HMDB | (-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol | HMDB | (-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol | HMDB | (-)-Epinephrine | HMDB | (R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol | HMDB | (R)-Adrenaline | HMDB | (R)-Epinephrine | HMDB | Adnephrine | HMDB | Adrenal | HMDB | Adrenine | HMDB | Adrin | HMDB | Ana-kit | HMDB | Bosmin | HMDB | Bronkaid mist | HMDB | Chelafrin | HMDB | Epifrin | HMDB | Epiglaufrin | HMDB | Epinephran | HMDB | Epirenan | HMDB | Eppy | HMDB | Exadrin | HMDB | Glauposine | HMDB | Hemisine | HMDB | Hemostasin | HMDB | Hemostatin | HMDB | Hypernephrin | HMDB | Isoptoepinal | HMDB | L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol | HMDB | L-Epinephrine | HMDB | L-Epirenamine | HMDB | L-Methylaminoethanolcatechol | HMDB | Levorenen | HMDB | Levorenin | HMDB | Levorenine | HMDB | Levoreninum | HMDB | Lyodrin | HMDB | Methylarterenol | HMDB | Mucidrina | HMDB | Nephridine | HMDB | Nieraline | HMDB | Paranephrin | HMDB | Primatene mist | HMDB | R-(-)-Epinephrine | HMDB | Renaglandin | HMDB | Renaleptine | HMDB | Renalina | HMDB | Renoform | HMDB | Renostypticin | HMDB | Renostyptin | HMDB | Scurenaline | HMDB | Simplene | HMDB | Styptirenal | HMDB | Supracapsulin | HMDB | Supranephrane | HMDB | Suprarenaline | HMDB | Suprarenin | HMDB | Surrenine | HMDB | Sus-phrine | HMDB | Takamina | HMDB | Vasoconstrictine | HMDB | Vasotonin | HMDB | 4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol | HMDB | Epinephrine bitartrate | HMDB | Epinephrine hydrogen tartrate | HMDB | Lyophrin | HMDB | Adrenaline bitartrate | HMDB | Adrenaline hydrochloride | HMDB | Epinephrine acetate | HMDB | Allergan brand OF adrenaline hydrochloride | HMDB | Epitrate | HMDB | Acetate, epinephrine | HMDB | Adrenaline acid tartrate | HMDB | Epinephrine hydrochloride | HMDB | Medihaler-epi | HMDB |
|
---|
Chemical Formula | C9H13NO3 |
---|
Average Molecular Weight | 183.2044 |
---|
Monoisotopic Molecular Weight | 183.089543287 |
---|
IUPAC Name | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
---|
Traditional Name | epinephrine |
---|
CAS Registry Number | 51-43-4 |
---|
SMILES | CNC[C@H](O)C1=CC(O)=C(O)C=C1 |
---|
InChI Identifier | InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1 |
---|
InChI Key | UCTWMZQNUQWSLP-VIFPVBQESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as catechols. Catechols are compounds containing a 1,2-benzenediol moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenols |
---|
Sub Class | Benzenediols |
---|
Direct Parent | Catechols |
---|
Alternative Parents | |
---|
Substituents | - Catechol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Monocyclic benzene moiety
- 1,2-aminoalcohol
- Secondary alcohol
- Secondary amine
- Secondary aliphatic amine
- Aromatic alcohol
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 211.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.18 mg/mL | Not Available | LogP | -1.37 | HANSCH,C & LEO,AJ (1985) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Epinephrine,1TMS,isomer #1 | CNC[C@H](O[Si](C)(C)C)C1=CC=C(O)C(O)=C1 | 1870.7 | Semi standard non polar | 33892256 | Epinephrine,1TMS,isomer #2 | CNC[C@H](O)C1=CC=C(O)C(O[Si](C)(C)C)=C1 | 1814.9 | Semi standard non polar | 33892256 | Epinephrine,1TMS,isomer #3 | CNC[C@H](O)C1=CC=C(O[Si](C)(C)C)C(O)=C1 | 1826.5 | Semi standard non polar | 33892256 | Epinephrine,1TMS,isomer #4 | CN(C[C@H](O)C1=CC=C(O)C(O)=C1)[Si](C)(C)C | 1994.8 | Semi standard non polar | 33892256 | Epinephrine,2TMS,isomer #1 | CNC[C@H](O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1 | 1804.8 | Semi standard non polar | 33892256 | Epinephrine,2TMS,isomer #2 | CNC[C@H](O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1 | 1804.1 | Semi standard non polar | 33892256 | Epinephrine,2TMS,isomer #3 | CN(C[C@H](O[Si](C)(C)C)C1=CC=C(O)C(O)=C1)[Si](C)(C)C | 1990.1 | Semi standard non polar | 33892256 | Epinephrine,2TMS,isomer #4 | CNC[C@H](O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1859.5 | Semi standard non polar | 33892256 | Epinephrine,2TMS,isomer #5 | CN(C[C@H](O)C1=CC=C(O)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1959.0 | Semi standard non polar | 33892256 | Epinephrine,2TMS,isomer #6 | CN(C[C@H](O)C1=CC=C(O[Si](C)(C)C)C(O)=C1)[Si](C)(C)C | 1985.3 | Semi standard non polar | 33892256 | Epinephrine,3TMS,isomer #1 | CNC[C@H](O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1 | 1856.3 | Semi standard non polar | 33892256 | Epinephrine,3TMS,isomer #2 | CN(C[C@H](O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O)=C1)[Si](C)(C)C | 1955.3 | Semi standard non polar | 33892256 | Epinephrine,3TMS,isomer #3 | CN(C[C@H](O[Si](C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1949.4 | Semi standard non polar | 33892256 | Epinephrine,3TMS,isomer #4 | CN(C[C@H](O)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2004.7 | Semi standard non polar | 33892256 | Epinephrine,4TMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 2023.0 | Semi standard non polar | 33892256 | Epinephrine,4TMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1994.6 | Standard non polar | 33892256 | Epinephrine,4TMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C)C1=CC=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1930.9 | Standard polar | 33892256 | Epinephrine,1TBDMS,isomer #1 | CNC[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O)=C1 | 2093.7 | Semi standard non polar | 33892256 | Epinephrine,1TBDMS,isomer #2 | CNC[C@H](O)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 2075.5 | Semi standard non polar | 33892256 | Epinephrine,1TBDMS,isomer #3 | CNC[C@H](O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 2090.6 | Semi standard non polar | 33892256 | Epinephrine,1TBDMS,isomer #4 | CN(C[C@H](O)C1=CC=C(O)C(O)=C1)[Si](C)(C)C(C)(C)C | 2230.5 | Semi standard non polar | 33892256 | Epinephrine,2TBDMS,isomer #1 | CNC[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1 | 2288.3 | Semi standard non polar | 33892256 | Epinephrine,2TBDMS,isomer #2 | CNC[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1 | 2294.3 | Semi standard non polar | 33892256 | Epinephrine,2TBDMS,isomer #3 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O)=C1)[Si](C)(C)C(C)(C)C | 2484.2 | Semi standard non polar | 33892256 | Epinephrine,2TBDMS,isomer #4 | CNC[C@H](O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2361.2 | Semi standard non polar | 33892256 | Epinephrine,2TBDMS,isomer #5 | CN(C[C@H](O)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2451.6 | Semi standard non polar | 33892256 | Epinephrine,2TBDMS,isomer #6 | CN(C[C@H](O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)[Si](C)(C)C(C)(C)C | 2489.7 | Semi standard non polar | 33892256 | Epinephrine,3TBDMS,isomer #1 | CNC[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1 | 2520.8 | Semi standard non polar | 33892256 | Epinephrine,3TBDMS,isomer #2 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O)=C1)[Si](C)(C)C(C)(C)C | 2698.9 | Semi standard non polar | 33892256 | Epinephrine,3TBDMS,isomer #3 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2690.3 | Semi standard non polar | 33892256 | Epinephrine,3TBDMS,isomer #4 | CN(C[C@H](O)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2724.8 | Semi standard non polar | 33892256 | Epinephrine,4TBDMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2938.8 | Semi standard non polar | 33892256 | Epinephrine,4TBDMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2768.0 | Standard non polar | 33892256 | Epinephrine,4TBDMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=C(O[Si](C)(C)C(C)(C)C)C(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2420.0 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Epinephrine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-014i-0900000000-5ca773e378035e522e65 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Epinephrine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-5ca773e378035e522e65 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9600000000-584d6e44f2be8cb4eeb1 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (3 TMS) - 70eV, Positive | splash10-00si-7639000000-5bde61303f7506ecea58 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Epinephrine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-014i-0900000000-7718bec49c1a109083e5 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0a4i-4900000000-ec5581e838e2a4a66139 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-004i-9200000000-4572448ba3dadff2d2a6 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-001i-0900000000-9da12d9c8551de2507be | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-03di-0900000000-12dd42d00be1feb2ea6f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-00di-0900000000-57c9bc614d9bbbfeed6b | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-00dj-0900000000-375b0df9797eb0a3db5f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0fdk-1900000000-04c230e802b08770ccd4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-014i-0900000000-b707acd2982b875d2b8a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-014i-0900000000-f3590054822872902032 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0a4i-1900000000-7d7916641e9f2b8c2a1d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0adi-8900000000-5bbc248c0ddc66e4fe40 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-004i-9300000000-af8ce8ce2cdd535404e9 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0159-0900000000-f2fafb87963f9f1c6960 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0uxr-2900000000-b54ca44315664cba912a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0udi-4900000000-881b25fed45874c66e13 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0ugi-9500000000-1fadd0dd0beb4816b39d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-004j-9000000000-61011b8f179c08d62b62 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Epinephrine LC-ESI-QFT , negative-QTOF | splash10-03di-0900000000-32c82b77af021d75c50c | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epinephrine 10V, Positive-QTOF | splash10-0159-0900000000-92937e3a48622f40baed | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epinephrine 20V, Positive-QTOF | splash10-014r-0900000000-b00275b1e8611c273f02 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epinephrine 40V, Positive-QTOF | splash10-0k9l-7900000000-065763dae156017492c9 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epinephrine 10V, Negative-QTOF | splash10-001i-0900000000-45c50917c3f404f38e71 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epinephrine 20V, Negative-QTOF | splash10-01q9-1900000000-713b357534dc0f81ae97 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Epinephrine 40V, Negative-QTOF | splash10-0a4i-5900000000-c6b1d16c9e7e36805557 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Bladder
- Epidermis
- Eye Lens
- Fibroblasts
- Intestine
- Kidney
- Liver
- Neuron
- Ovary
- Pancreas
- Placenta
- Platelet
- Skeletal Muscle
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.00164 +/- 0.00012 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00029 +/- 0.000021 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.00072 (0.00049-0.0013) uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0.0003 +/- 0.00003 uM | Adult (>18 years old) | Male | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.0 (0.0-0.00022) uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000235 +/- 0.00003277 uM | Not Specified | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.034 (0.0063-0.062) uM | Adult (>18 years old) | Female | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.00024 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0057 +/- 0.00092 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.002 +/- 0.00099 umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0052 (0.00043-0.0099) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.016 (0.001-0.089) umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0021 (0.00098-0.0052) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.00241 +/- 0.00057 uM | Adult (>18 years old) | Both | Head trauma | | details | Blood | Detected and Quantified | 0.000077 +/- 0.000025 uM | Adult (>18 years old) | Female | Addison's disease | | details | Blood | Detected and Quantified | 0.001 +/- 0.00036 uM | Adult (>18 years old) | Both | Subarachnoid haemorrhage | | details | Blood | Detected and Quantified | 0.00014 +/- 0.000036 uM | Adult (>18 years old) | Male | Addison's disease | | details | Blood | Detected and Quantified | 0.00029 (0.00005-0.00054) uM | Adult (>18 years old) | Both | Pheochromocytoma | | details | Blood | Detected and Quantified | 0.0025 (0.0002-0.0048) uM | Adult (>18 years old) | Both | Pheochromocytoma | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000453 +/- 0.00004916 uM | Adult (>18 years old) | Not Specified | borderline hypertensives | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000147 +/- 0.000109 uM | Adult (>18 years old) | Not Specified | Cerebral infarction, headache, paresthesia and ununconfirmed suspicion of leucemic infaction or brain metastasis with normal CSF value | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000109 uM | Adult (>18 years old) | Not Specified | Cerebral infarction, headache, paresthesia and ununconfirmed suspicion of leucemic infaction or brain metastasis with normal CSF value but renal insufficiency | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000251 uM | Adult (>18 years old) | Not Specified | Haemorrhagic infarction | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000300 uM | Adult (>18 years old) | Not Specified | Bacterial meningitis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000481 uM | Adult (>18 years old) | Not Specified | Leucemic meningiosa | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.000153 uM | Adult (>18 years old) | Not Specified | Encephalitis | | details | Urine | Detected and Quantified | 0.011 +/- 0.0022 umol/mmol creatinine | Adult (>18 years old) | Both | Exercise | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Schizophrenia | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Addison's Disease |
---|
- Bornstein SR, Breidert M, Ehrhart-Bornstein M, Kloos B, Scherbaum WA: Plasma catecholamines in patients with Addison's disease. Clin Endocrinol (Oxf). 1995 Feb;42(2):215-8. [PubMed:7704967 ]
| Subarachnoid hemorrhage |
---|
- Lambert G, Naredi S, Eden E, Rydenhag B, Friberg P: Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus. Brain Res Bull. 2002 May;58(1):77-82. [PubMed:12121816 ]
| Pheochromocytoma |
---|
- Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW: Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998 Jun;83(6):2175-85. [PubMed:9626157 ]
| Head injury |
---|
- Lambert G, Naredi S, Eden E, Rydenhag B, Friberg P: Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus. Brain Res Bull. 2002 May;58(1):77-82. [PubMed:12121816 ]
| Cerebral infarction |
---|
- Ratge D, Bauersfeld W, Wisser H: The relationship of free and conjugated catecholamines in plasma and cerebrospinal fluid in cerebral and meningeal disease. J Neural Transm. 1985;62(3-4):267-84. [PubMed:4031843 ]
| Bacterial meningitis |
---|
- Ratge D, Bauersfeld W, Wisser H: The relationship of free and conjugated catecholamines in plasma and cerebrospinal fluid in cerebral and meningeal disease. J Neural Transm. 1985;62(3-4):267-84. [PubMed:4031843 ]
| Encephalitis |
---|
- Ratge D, Bauersfeld W, Wisser H: The relationship of free and conjugated catecholamines in plasma and cerebrospinal fluid in cerebral and meningeal disease. J Neural Transm. 1985;62(3-4):267-84. [PubMed:4031843 ]
| Schizophrenia |
---|
- Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015. [PubMed:25729574 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB00668 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB021889 |
---|
KNApSAcK ID | C00029643 |
---|
Chemspider ID | 5611 |
---|
KEGG Compound ID | C00788 |
---|
BioCyc ID | L-EPINEPHRINE |
---|
BiGG ID | 35997 |
---|
Wikipedia Link | Epinephrine |
---|
METLIN ID | 5127 |
---|
PubChem Compound | 5816 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 28918 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | ADRNL |
---|
MarkerDB ID | MDB00000035 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Singer, Robert A.; Carreira, Erick M. An in situ procedure for catalytic, enantioselective acetate aldol addition. Application to the synthesis of (R)-(-)-epinephrine. Tetrahedron Letters (1997), 38(6), 927-930. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Blagitko N, Schulz U, Schinzel AA, Ropers HH, Kalscheuer VM: gamma2-COP, a novel imprinted gene on chromosome 7q32, defines a new imprinting cluster in the human genome. Hum Mol Genet. 1999 Dec;8(13):2387-96. [PubMed:10556286 ]
- Goldstein DS, Eisenhofer G, Kopin IJ: Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003 Jun;305(3):800-11. Epub 2003 Mar 20. [PubMed:12649306 ]
- Kurtis JD, Friedman JF, Leenstra T, Langdon GC, Wu HW, Manalo DL, Su L, Jiz M, Jarilla B, Pablo AO, McGarvey ST, Olveda RM, Acosta LP: Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum. Clin Infect Dis. 2006 Jun 15;42(12):1692-8. Epub 2006 May 12. [PubMed:16705573 ]
- Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW: Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab. 1998 Jun;83(6):2175-85. [PubMed:9626157 ]
- Igdoura SA, Gafuik C, Mertineit C, Saberi F, Pshezhetsky AV, Potier M, Trasler JM, Gravel RA: Cloning of the cDNA and gene encoding mouse lysosomal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts. Hum Mol Genet. 1998 Jan;7(1):115-21. [PubMed:9384611 ]
- Kaufer D, Ogle WO, Pincus ZS, Clark KL, Nicholas AC, Dinkel KM, Dumas TC, Ferguson D, Lee AL, Winters MA, Sapolsky RM: Restructuring the neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci. 2004 Sep;7(9):947-53. Epub 2004 Aug 8. [PubMed:15300253 ]
- Yasuda G, Umemura S, Ishii M: Characterization of bunazosin-sensitive alpha1-adrenoceptors in human renal medulla. J Cardiovasc Pharmacol. 1997 Aug;30(2):163-8. [PubMed:9269942 ]
- Gear AR, Camerini D: Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation. 2003 Jun;10(3-4):335-50. [PubMed:12851650 ]
- Wilson BS, Petrella E, Lowe SR, Lien K, Mackensen DG, Gridley DS, Stickney DR: Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617. Cancer Res. 1990 May 15;50(10):3124-30. [PubMed:2159374 ]
- Blakely RD, Apparsundaram S: Structural diversity in the catecholamine transporter gene family: molecular cloning and characterization of an L-epinephrine transporter from bullfrog sympathetic ganglia. Adv Pharmacol. 1998;42:206-10. [PubMed:9327880 ]
- Belloni AS, Albertin G, Forneris ML, Nussdorfer GG: Proadrenomedullin-derived peptides as autocrine-paracrine regulators of cell growth. Histol Histopathol. 2001 Oct;16(4):1263-74. [PubMed:11642745 ]
- Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM: A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Clin Endocrinol (Oxf). 2004 Dec;61(6):675-82. [PubMed:15579180 ]
- Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Owen WE, Bunker AM, Meikle AW: Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem. 2006 Aug;52(8):1559-67. Epub 2006 Jun 15. [PubMed:16777916 ]
- Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K: Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet. 1992 Mar 28;339(8796):770-3. [PubMed:1347802 ]
- Bornstein SR, Breidert M, Ehrhart-Bornstein M, Kloos B, Scherbaum WA: Plasma catecholamines in patients with Addison's disease. Clin Endocrinol (Oxf). 1995 Feb;42(2):215-8. [PubMed:7704967 ]
- Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50. [PubMed:12834252 ]
- Hiroi N, Yanagisawa R, Yoshida-Hiroi M, Endo T, Kawase T, Tsuchida Y, Toyama K, Shibuya K, Nakata K, Yoshino G: Retroperitoneal hemorrhage due to bilateral adrenal metastases from lung adenocarcinoma. J Endocrinol Invest. 2006 Jun;29(6):551-4. [PubMed:16840834 ]
- Kennedy B, Bigby TD, Ziegler MG: Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels. J Clin Invest. 1995 Jun;95(6):2896-902. [PubMed:7769131 ]
- Panholzer TJ, Beyer J, Lichtwald K: Coupled-column liquid chromatographic analysis of catecholamines, serotonin, and metabolites in human urine. Clin Chem. 1999 Feb;45(2):262-8. [PubMed:9931050 ]
- De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, Jenkins FJ, Ryan ND: A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol Psychiatry. 1999 May 15;45(10):1259-70. [PubMed:10349032 ]
- Brunk E, Sahoo S, Zielinski DC, Altunkaya A, Drager A, Mih N, Gatto F, Nilsson A, Preciat Gonzalez GA, Aurich MK, Prlic A, Sastry A, Danielsdottir AD, Heinken A, Noronha A, Rose PW, Burley SK, Fleming RMT, Nielsen J, Thiele I, Palsson BO: Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat Biotechnol. 2018 Mar;36(3):272-281. doi: 10.1038/nbt.4072. Epub 2018 Feb 19. [PubMed:29457794 ]
|
---|